Costimulatory Signals Through B7.1/CD28 Prevent T Cell Apoptosis during Target Cell Lysis

Journal of Immunology

Volumn 159, Issue 8, 1997, Pages 3808-3815

  Daniel, Peter T ^a   Kroidl, Arne ^a   Cayeux, Sophie ^a   Bargou, Ralf ^a   Blankenstein, Thomas ^a   Dörken, Bernd ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; FAS ANTIGEN; FAS LIGAND; FASLG PROTEIN, HUMAN; LIGAND; MEMBRANE PROTEIN;

APOPTOSIS; ARTICLE; BREAST TUMOR; CELL COMMUNICATION; CELL CULTURE; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DRUG EFFECT; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION;

ANTIGENS, CD28; ANTIGENS, CD80; ANTIGENS, CD95; APOPTOSIS; BREAST NEOPLASMS; CELL COMMUNICATION; CYTOTOXICITY, IMMUNOLOGIC; FAS LIGAND PROTEIN; HUMANS; LIGANDS; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0031572579     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Schwartz, R. 1990. A cell culture model for T lymphocyte clonal anergy. Science 248:1349.
2. Freeman, G., A. Freedman, J. Segil, G. Lee, J. Whitman, and L. Nadler. 1989. B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J. Immunol. 143:2714.
3. Guinan, E., J. Gribben, V. Boussiotis, G. Freeman, and L. Nadler. 1994. Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity. Blood 84:3261.
4. Bluestone, J. 1995. New perspectives of CD28-B7-mediated T cell costimulation. Immunity 2:555.
5. Boise, L., A. Minn, P. Noel, C. June, M. Accavitti, T. Lindsten, and C. Thompson. 1995. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-xL. Immunity 3:87.
6. Cayeux, S., C. Beck, A. Aicher, B. Dörken, and T. Blankenstein. 1995. Tumor cells cotransfected with interleukin-7 and B7.1 genes induce CD25 and CD28 on tumor infiltrating T lymphocytes and are strong vaccines. Eur J. Immunol 25: 2325.
7. Cayeux, S., C. Beck, B. Dörken, and T. Blankenstein. 1996. Coexpression of Interleukin-4 and B7.1 in murine tumor cells leads to improved tumor rejection and vaccine effect compared to single gene transfectants and a classical adjuvant. Hum. Gene Ther. 7:525.
8. Lupton, S. D., L. L. Brunton, V. A. Kalberg, and R. W. Overall. 1991. Dominant positive and negative selection using a hygromycin phosphotransferase-thymidine kinase fusion gene. Mol. Cell. Biol. 11:3374.
9. Miller, D., and C. Buttimore. 1986. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell. Biol. 6:2895.
10. Li, W., T. Diamantstein, and T. Blankenstein. 1990. Lack of tumorigenicity of interleukin 4 autocrine growing cells seems related to the anti-tumor function of interleukin 4. Mol. Immunol. 27:1331.
11. Lanzavecchia, A. 1986. Is the T cell receptor involved in T cell killing? Nature 319:778.
12. Nicoletti, I., G. Migliorati, M. C. Pagliacci, F. Grignani, and C. Riccardi. 1991. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 139:271.
13. Bargou, R. C., K. Bommert, P. Weinmann, P. T. Daniel, C. Wagener, M. Y. Mapara, and B. Dorken. 1995. Induction of Bax-alpha precedes apoptosis in a human B lymphoma cell line: potential role of the bcl-2 gene family in surface IgM-mediated apoptosis. Eur. J. Immunol. 25:770.
14. Matzinger, P. 1991. The JAM test: a simple assay for DNA fragmentation and cell death. J. Immunol. Methods 145:185.
15. Coney, L. R., P. T. Daniel, D. Sanborn, J. Dhein, K. M. Debatin, P. H. Krammer, and V. J. Zurawski. 1994. Apoptotic cell death induced by a mouse-human anti-APO-1 chimeric antibody leads to tumor regression. Int. J. Cancer 58:562.
16. Bargou, R. C., M. Y. Mapara, C. Zugck, P. T. Daniel, M. Pawlita, H. Döhner, and B. Dörken. 1993. Characterization of a novel Hodgkin cell line, HD-MyZ, with myelomonocytic features mimicking Hodgkin's disease in severe combined immunodeficient mice. J. Exp. Med. 177:1257.
17. Bargou, R. C., P. T. Daniel, M. Y. Mapara, K. Bommert, C. Wagener, B. Kallinich, H. D. Royer, and B. Dorken. 1995. Expression of the bcl-2 gene family in normal and malignant breast tissue: low bax-alpha expression in tumor cells correlates with resistance towards apoptosis. Int. J. Cancer 60:854.
18. Wesselborg S., O. Janssen, and D. Kabelitz. 1993. Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells. J. Immunol. 150:4338.
19. Suhrbier, A., S. Burrows, A. Fernan, M. Lavin, G. Baxter, and D. Moss. 1993. Peptide epitope induced apoptosis of human cytotoxic T lymphocytes. J. Immunol. 150:2169.
20. Smith, C. A., G. T. Williams, R. Kingston, E. J. Jenkinson, and J. J. Owen. 1989. Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature 337:181.
21. Dhein, J., H. Walczak, C. Bäumler, K. Debatin, and P. Krammer. 1995. Autocrine T cell suicide by APO-1/CD95. Nature 373:438.
22. Daniel, P. T., U. Oettinger, M. Y. Mapara, K. Bommert, R. Bargou, and B. Dörken. 1997. Activation and activation-induced death of human tonsillar B cells and Burkitt lymphoma cells: lack of CD95 (Fas/APO-1) ligand expression and function. Eur. J. Immunol. 27:1029.
23. Dhein, J., P. T. Daniel, B. C. Trauth, A. Oehm, P. Möller, and P. H. Krammer. 1992. Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens. J. Immunol. 149:3166.
24. Webb, S., C. Morris, and J. Sprent. 1990. Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity. Cell 63:1249.
25. Daniel, P. T., and P. H. Krammer. 1994. Activation induces sensitivity towards APO-1 (CD95)-mediated apoptosis in human B cells. J. Immunol. 153:5624.
26. Krammer, P. H., I. Behrmann, P. T. Daniel, J. Dhein, and K. M. Debatin. 1994. Regulation of apoptosis in the immune system. Curr. Opin. Immunol. 6:279.
27. O'Connell, J., G. C. O'Sullivan, J. K. Collins, and F. Shanahan. 1996. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J. Exp. Med. 184:1075.
28. Griffith, T. S., T. Brunner, S. M. Fletcher, D. R. Green, and T. A. Ferguson. 1995. Fas-ligand-induced apoptosis as a mechanism of immune privilege. Science 270: 1189.
29. Griffith, T. S., X. Yu, J. M. Herndon, D. R. Green, and T. A. Ferguson. 1996. CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance. Immunity 5:7.
30. Bellgrau, D., D. Gold, H. Selawry, J. Moore, A. Franzusoff, and R. C. Duke. 1995. A role for CD95 ligand in preventing graft rejection. Nature 377:630.
31. Zheng, L., G. Fisher, R. G. Miller, J. Peschon, D. H. Lynch, and M. J. Lenardo. 1995. Induction of apoptosis in mature T cells by tumor necrosis factor. Nature 377:348.
32. Lin, R.-H., Y.-W. Hwang, B.-C. Yang, and C.-S. Lin. 1997. TNF receptor-2-triggered apoptosis is associated with the down-regulation of Bcl-xL on activated T cells and can be prevented by CD28 costimulation. J. Immunol. 158:598.
33. Van Parijis, L., A. Ibraghimov, and A. K. Abbas. 1996. The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity 4:321.
34. Boehme, S. A., L. Zheng, and M. J. Lenardo. 1995. Analysis of the CD4 coreceptor and activation-induced costimulatory molecules in antigen-mediated mature T lymphocyte death. J. Immunol. 155:1703.
35. Hutchcroft, J. E., and B. E. Bierer. 1996. Signaling through CD28/CTLA-4 family receptors: puzzling participation of phosphatidylinositol-3 kinase. J. Immunol. 156:4071.
36. Owen-Schaub, L., S. Yonehara, W. d. Crump, and E. A. Grimm. 1992. DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell. Immunol. 140:197.
37. Klas, C., K.-M. Debatin, R. R. Jonker, and P. H. Krammer. 1993. Activation interferes with the APO-1 pathway in mature human T cells. Int. Immunol. 5:625.
38. Nishio, M., J. Spielman, R. K. Lee, D. L. Nelson, and E. R. Podack. 1996. CD80 (B7.1) and CD54 (intracellular adhesion molecule-1) induce target cell susceptibility to promiscuous cytotoxic T cell lysis. J. Immunol. 157:4347.
39. Miller, R. 1980. An immunological suppressor cell inactivating cytotoxic T-lymphocyte precursor cells recognizing it. Nature 287:544.
40. Rammensee, H. G., P. J. Fink, and M. J. Bevan. 1984. Functional clonal deletion of class I-specific cytotoxic T lymphocytes by veto cells that express antigen. J. Immunol. 133:2390.
41. Rammensee, H. 1989. Veto function in vitro and in vivo. Int. Rev. Immunol. 4:668.
42. Lau, H. T., M. Yu, A. Fontana, and C. J. Stoeckert. 1996. Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science 273:109.